abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to medicine and pharmacology and represents lyophilised medication for treatment of chronic viral hepatitis B or C and AIDS, which contains alpha fetoprotein (AFP) 60-150 mcg, interferon α 3000000-6000000 U and dextran 2-6 mg. n EFFECT: invention ensures improvement of treatment results, reduction of complications and treatment terms. n 4 cl, 9 ex |